頭蓋顎顔面インプラントの世界市場

◆英語タイトル:Craniomaxillofacial Implants Market (Location: Internal and External Fixators; Composition: Calcium Ceramics, Metals and Alloys, Polymers, and Biologic Materials; Nature: Non-resorbable and Resorbable Fixators; Type: Plate and Screw Fixator Systems, Bone Graft Substitutes, Distraction Systems, and TMJ Replacement Devices) - Global Industry Analysis, Size, Share, Growth, Trends and Forecast 2014 - 2022
◆商品コード:TMR602214
◆発行会社(調査会社):Transparency Market Research
◆発行日:2015年6月
◆ページ数:173
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆調査対象地域:グローバル
◆産業分野:医療機器
◆販売価格オプション(消費税別)
Single UserUSD4,795 ⇒換算¥541,835見積依頼/購入/質問フォーム
Multi UserUSD7,795 ⇒換算¥880,835見積依頼/購入/質問フォーム
Corporate LicenseUSD10,795 ⇒換算¥1,219,835見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご確認ください。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日~2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送いたしますので、請求書発行日より2ヶ月以内に銀行振込にて支払をお願いします。(支払期限と方法は調整可能、振込先:三菱東京UFJ銀行/京橋支店/H&Iグローバルリサーチ株式会社)
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はTransparency Market Research社の日本における正規販売代理店です。Transparency Market Research社の概要及び新刊レポートはこちらでご確認いただけます。
当調査レポートでは、頭蓋顎顔面インプラントの世界市場について調査・分析し、頭蓋顎顔面インプラントの世界市場概要、市場動向、市場規模、主要地域別分析、関連企業情報などをお届けいたします。
【レポートの概要】

This report on the craniomaxillofacial implants market studies the current and future prospects of the global market. Craniomaxillofacial implants are rapidly gaining popularity in the global market due to increasing facial deformities and dislocations and growing awareness regarding the availability of technologically advanced implants. A variety of craniomaxillofacial implants are used to treat facial traumas, including metallic and non-metallic fixators. This report comprises an elaborate executive summary, which includes a market snapshot that provides information about various segments and sub-segments of the craniomaxillofacial implants market. It also provides information and data analysis of the global craniomaxillofacial implants market with respect to market segments based on the type of location, composition, nature, type, and their geographic markets.

Based on location, the craniomaxillofacial implants market has been segmented into two major categories: internal and external fixators. Based on composition, the market has been categorized into four segments: calcium ceramics, metals and alloys, polymers, and biologic materials. Furthermore, based on nature, the craniomaxillofacial implants market has been segmented into non-resorbable and resorbable fixators. The craniomaxillofacial implants market has also been segmented based on product type that includes plate and screw fixator systems, bone graft substitutes, distraction systems, and TMJ replacement devices. The market segments have been extensively analyzed based on usefulness, efficacy, revenue, and geographical coverage. The market size and forecast in terms of USD million for each segment has been provided for the period from 2012 to 2022. The report also provides the compound annual growth rate (CAGR %) for each market segment for the forecast period from 2014 to 2022, considering 2013 as the base year.

Geographically, the craniomaxillofacial implants market has been categorized into six major regions: North America, Europe, Asia Pacific, Latin America, Middle East and North Africa (MENA), and Rest of the World (RoW). The market size and forecast for each of these regions has been provided for the period from 2012 to 2022, along with their respective CAGRs for the forecast period from 2014 to 2022, considering 2013 as the base year. The research study also covers the competitive scenario in these regions. A detailed qualitative analysis of factors responsible for driving and restraining the growth of the market and future opportunities has been provided in the market overview section. This section of the report also provides market attractiveness analysis, value chain analysis, Porter’s Five Forces Analysis, and market share analysis by key players, thus presenting a thorough analysis of the overall competitive scenario in the global craniomaxillofacial implants market.

A list of recommendations has been provided for new entrants as well as existing market players to assist them in taking strategic initiatives to establish a strong presence in the market. The report also profiles major players in the craniomaxillofacial implants market based on various attributes such as company overview, financial overview, product portfolio, business strategies, and recent developments. Major players profiled in this report include DePuy Synthes, Stryker Corporation, Biomet, Inc., KLS Martin LP, OsteoMed, Anatomics Pty. Ltd., BIOPORE Surgical Implants, Calavera Surgical, ELLA-CS, s.r.o., Matrix Surgical USA, Medical Vision Australia Holdings, Poriferous, LLC, General Implants GmbH, GPC Medical Ltd., INION, INC., Narang Medical Limited, Ningbo Cibei Medical Treatment Appliance Co., Ltd., NRV OrthoTech Pvt. Ltd, O & M Medical GmbH, Ortho Max Manufacturing Company Pvt. Ltd., Osteotec Ltd., Rebstock Instruments GmbH, S.H. Pitkar Orthotools Pvt. Ltd., Shenzhen World Surgery Medical Device Technology Co., Ltd., B. Braun Melsungen AG, Boston Medical Products, Inc., Cavendish Implants Ltd., CONMED, Integra LifeSciences Holdings Corporation, Medartis AG, and Medtronic, Inc.

【レポートの目次】

Chapter 1 Introduction
1.1 Report Description
1.2 Market Segmentation
1.3 Research Methodology

Chapter 2 Executive Summary
2.1 Market Snapshot: Global Craniomaxillofacial Implants Market
2.2 Comparative Analysis: Global Craniomaxillofacial Implants Market Revenue, by Geography, 2013 and 2022 (Value %)

Chapter 3 Global Craniomaxillofacial Implants Market Overview
3.1 Introduction
3.2 Market Drivers
3.2.1 Constant rise in incidence of facial fractures
3.2.2 Emergence of new technological advancements and minimally invasive techniques in the field of trauma fixation
3.2.3 Increased health care expenditure globally
3.3 Market Restraints
3.3.1 High cost of craniomaxillofacial surgery
3.3.2 Absence of health insurance schemes in developing countries
3.4 Market Opportunities
3.4.1 Shift from metallic to nonmetallic (bioresorbable) material for internal fixators
3.4.2 Emerging economies to offer sustained growth opportunities
3.5 Porter’s Five Forces Analysis: Global Craniomaxillofacial Implants Market
3.5.1 Bargaining Power of Suppliers
3.5.2 Bargaining Power of Buyers
3.5.3 Threat of Substitutes
3.5.4 Threat of New Entrants
3.5.5 Competitive Rivalry
3.6 Regulatory Framework: Global Craniomaxillofacial Implants Market
3.7 Value Chain Analysis: Global Craniomaxillofacial Implants Market
3.8 Market Attractiveness Analysis: Global Craniomaxillofacial Implants Market, by Geography
3.9 Competitive Landscape
3.9.1 Market Share by Key Players of the Global Craniomaxillofacial Implants Market, 2013 (%)

Chapter 4 Global Craniomaxillofacial Implants Market, by Location
4.1 Overview
4.1.1 Global Craniomaxillofacial Implants Market Revenue, by Location, 2012 – 2022 (USD Million)
4.2 Internal Fixators
4.2.1 Global Internal Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
4.3 External Fixators
4.3.1 Global External Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

Chapter 5 Global Craniomaxillofacial Implants Market, by Composition
5.1 Overview
5.1.1 Global Craniomaxillofacial Implants Market Revenue, by Composition, 2012 – 2022 (USD Million)
5.1.2 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Composition, 2013 and 2022 (Value %)
5.2 Calcium Ceramics
5.2.1 Global Calcium Ceramics Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
5.3 Metals and Alloys
5.3.1 Global Metals and Alloys Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
5.4 Polymers
5.4.1 Global Polymers Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
5.5 Biologic Materials
5.5.1 Global Biologic Materials Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

Chapter 6 Global Craniomaxillofacial Implants Market, by Nature
6.1 Overview
6.1.1 Global Craniomaxillofacial Implants Market Revenue, by Nature, 2012 – 2022 (USD Million)
6.2 Non-resorbable Fixators
6.2.1 Global Non-resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
6.3 Resorbable Fixators
6.3.1 Global Resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

Chapter 7 Global Craniomaxillofacial Implants Market, by Product
7.1 Overview
7.1.1 Global Craniomaxillofacial Implants Market Revenue, by Product, 2012 – 2022 (USD Million)
7.1.2 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Type, 2013 and 2022 (Value %)
7.2 Plate and Screw Fixator Systems
7.2.1 Global Plate and Screw Fixator Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
7.3 Bone Graft Substitutes
7.3.1 Global Bone Graft Substitutes in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
7.4 Distraction Systems
7.4.1 Global Distraction Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
7.5 Temporomandibular Joint (TMJ) Replacement Devices
7.5.1 Global TMJ Replacement Devices in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

Chapter 8 Global Craniomaxillofacial Implants Market, by Geography
8.1 Overview
8.1.1 Global Craniomaxillofacial Implants Market Revenue, by Geography, 2012 – 2022 (USD Million)
8.2 North America
8.2.1 North America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
8.2.2 U.S. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.2.3 Canada Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.3 Europe
8.3.1 Europe Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
8.3.2 U.K. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.3.3 Germany Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.3.4 France Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.3.5 Rest of Europe Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.4 Asia Pacific
8.4.1 Asia Pacific Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
8.4.2 Japan Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.4.3 China Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.4.4 Rest of Asia Pacific Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.5 Latin America
8.5.1 Latin America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
8.5.2 Brazil Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.5.3 Rest of Latin America Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.6 MENA
8.6.1 MENA Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)
8.6.2 UAE Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.6.3 Rest of MENA Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)
8.7 Rest of the World (RoW)
8.7.1 Rest of the World Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

Chapter 9 Recommendations

Chapter 10 Company Profiles
10.1 Anatomics Pty Ltd
10.1.1 Company Overview
10.1.2 Financial Overview
10.1.3 Product Portfolio
10.1.4 Business Strategies
10.1.5 Recent Developments
10.2 B. Braun Melsungen AG
10.2.1 Company Overview
10.2.2 Financial Overview
10.2.3 Product Portfolio
10.2.4 Business Strategy
10.2.5 Recent Developments
10.3 Biomet, Inc.
10.3.1 Company Overview
10.3.2 Financial Overview
10.3.3 Product Portfolio
10.3.4 Business Strategies
10.3.5 Recent Developments
10.4 BIOPORE Surgicals
10.4.1 Company Overview
10.4.2 Financial Overview
10.4.3 Product Portfolio
10.4.4 Business Strategies
10.5 Boston Medical Products, Inc.
10.5.1 Company Overview
10.5.2 Financial Overview
10.5.3 Product Portfolio
10.5.4 Business Strategies
10.5.5 Recent Developments
10.6 Calavera Surgical Design, Inc.
10.6.1 Company Overview
10.6.2 Financial Overview
10.6.3 Product Portfolio
10.6.4 Business Strategies
10.6.5 Recent Developments
10.7 Cavendish Implants Ltd.
10.7.1 Company Overview
10.7.2 Financial Overview
10.7.3 Product Portfolio
10.7.4 Business Strategies
10.7.5 Recent Developments
10.8 CONMED Corporation
10.8.1 Company Overview
10.8.2 Financial Overview
10.8.3 Product Portfolio
10.8.4 Business Strategies
10.8.5 Recent Developments
10.9 DePuySynthes, Inc. (a J & J Company)
10.9.1 Company Overview
10.9.2 Financial Overview
10.9.3 Product Portfolio
10.9.4 Business Strategies
10.9.5 Recent Developments
10.10 ELLA-CS, s.r.o.
10.10.1 Company Overview
10.10.2 Financial Overview
10.10.3 Product Portfolio
10.10.4 Business Strategies
10.10.5 Recent Developments
10.11 General Implants GmbH
10.11.1 Company Overview
10.11.2 Financial Overview
10.11.3 Product Portfolio
10.11.4 Business Strategies
10.11.5 Recent Developments
10.12 GPC Medical Limited
10.12.1 Company Overview
10.12.2 Financial Overview
10.12.3 Product Portfolio
10.12.4 Business Strategies
10.12.5 Recent Developments
10.13 Integra LifeSciences Corporation
10.13.1 Company Overview
10.13.2 Financial Overview
10.13.3 Product Portfolio
10.13.4 Business Strategies
10.13.5 Recent Developments
10.14 KLS Martin LP
10.14.1 Company Overview
10.14.2 Financial Overview
10.14.3 Product Portfolio
10.14.4 Business Strategies
10.14.5 Recent Developments
10.15 Matrix Surgical USA
10.15.1 Company Overview
10.15.2 Financial Overview
10.15.3 Product Portfolio
10.15.4 Business Strategies
10.15.5 Recent Developments
10.16 Medartis AG
10.16.1 Company Overview
10.16.2 Financial Overview
10.16.3 Product Portfolio
10.16.4 Business Strategies
10.16.5 Recent Developments
10.17 Medical Vision Australia Holdings
10.17.1 Company Overview
10.17.2 Financial Overview
10.17.3 Product Portfolio
10.17.4 Business Strategies
10.17.5 Recent Developments
10.18 Medtronic, Inc.
10.18.1 Company Overview
10.18.2 Financial Overview
10.18.3 Product Portfolio
10.18.4 Business Strategies
10.18.5 Recent Developments
10.19 Narang Medical Limited
10.19.1 Company Overview
10.19.2 Financial Overview
10.19.3 Product Portfolio
10.19.4 Business Strategies
10.19.5 Recent Developments
10.20 Naton Medical Group
10.20.1 Company Overview
10.20.2 Financial Overview
10.20.3 Product Portfolio
10.20.4 Business Strategies
10.20.5 Recent Developments
10.21 Ningbo Cibei Medical Treatment Appliance Co. Ltd.
10.21.1 Company Overview
10.21.2 Financial Overview
10.21.3 Product Portfolio
10.21.4 Business Strategies
10.22 NRV OrthoTech Pvt Ltd
10.22.1 Company Overview
10.22.2 Financial Overview
10.22.3 Product Portfolio
10.22.4 Business Strategies
10.22.5 Recent Developments
10.23 O & M Medical GmbH
10.23.1 Company Overview
10.23.2 Financial Overview
10.23.3 Product Portfolio
10.23.4 Business Strategies
10.23.5 Recent Developments
10.24 Ortho Max Manufacturing Company Pvt. Ltd.
10.24.1 Company Overview
10.24.2 Financial Overview
10.24.3 Product Portfolio
10.24.4 Business Strategies
10.24.5 Recent Developments
10.25 OsteoMed
10.25.1 Company Overview
10.25.2 Financial Overview
10.25.3 Product Portfolio
10.25.4 Business Strategies
10.25.5 Recent Developments
10.26 Osteotec Ltd
10.26.1 Company Overview
10.26.2 Financial Overview
10.26.3 Product Portfolio
10.26.4 Business Strategies
10.26.5 Recent Developments
10.27 Poriferous, LLC
10.27.1 Company Overview
10.27.2 Financial Overview
10.27.3 Product Portfolio
10.27.4 Business Strategies
10.27.5 Recent Developments
10.28 Rebstock Instruments GmbH
10.28.1 Company Overview
10.28.2 Financial Overview
10.28.3 Product Portfolio
10.28.4 Business Strategies
10.28.5 Recent Developments
10.29 S. H. Pitkar Orthotools Pvt. Ltd.
10.29.1 Company Overview
10.29.2 Financial Overview
10.29.3 Product Portfolio
10.29.4 Business Strategies
10.29.5 Recent Developments
10.30 Shenzhen World Surgery Medical Device Technology Co., Ltd
10.30.1 Company Overview
10.30.2 Financial Overview
10.30.3 Product Portfolio
10.30.4 Business Strategies
10.30.5 Recent Developments
10.31 Stryker Corporation
10.31.1 Company Overview
10.31.2 Financial Overview
10.31.3 Product Portfolio
10.31.4 Business Strategies
10.31.5 Recent Developments
10.32 Zimmer Holdings, Inc.
10.32.1 Company Overview
10.32.2 Financial Overview
10.32.3 Product Portfolio
10.32.4 Business Strategies
10.32.5 Recent Developments

List of Figures

FIG. 1 Craniomaxillofacial Implants: Market Segmentation

FIG. 2 Global Craniomaxillofacial Implants Market, by Location and Composition, 2013 (USD Million)

FIG. 3 Global Craniomaxillofacial Implants Market, by Nature and Type, 2013 (USD Million)

FIG. 4 Comparative Analysis: Global Craniomaxillofacial Implants Market Revenue, by Geography, 2013 and 2022 (Value %)

FIG. 5 Porter’s Five Forces Analysis: Global Craniomaxillofacial Implants Market

FIG. 6 Value Chain Analysis: Global Craniomaxillofacial Implants Market

FIG. 7 Market Attractiveness Analysis: Global Craniomaxillofacial Implants Market, by Geography (2013)

FIG. 8 Craniomaxillofacial Implants Market Share by Key Players, 2013 (%)

FIG. 9 Global Internal Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 10 Global External Fixators of Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 11 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Composition, 2013 and 2022 (Value %)

FIG. 12 Global Calcium Ceramics Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 13 Global Metals and Alloys Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 14 Global Polymers Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 15 Global Biologic Materials Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 16 Global Non-resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 17 Global Resorbable Fixators in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 18 Comparative Analysis: Global Craniomaxillofacial Implants Market, by Type, 2013 and 2022 (Value %)

FIG. 19 Global Plate and Screw Fixator Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 20 Global Bone Graft Substitutes in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 21 Global Distraction Systems in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 22 Global TMJ Replacement Devices in Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 23 U.S. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 24 Canada Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 25 U.K. Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 26 Germany Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 27 France Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 28 Rest of Europe Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 29 Japan Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 30 China Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 31 Rest of Asia Pacific Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 32 Brazil Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 33 Rest of Latin America Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 34 UAE Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 35 Rest of MENA Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 36 Rest of the World Craniomaxillofacial Implants Market Revenue, 2012 – 2022 (USD Million)

FIG. 37 B. Braun Melsungen AG: Annual Revenue, 2011 - 2013 (USD Million)

FIG. 38 CONMED: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 39 Johnson and Johnson Annual Revenue (USD Million) of Medical Devices Segment, 2012 – 2014

FIG. 40 Integra LifeSciences Corporation: Annual Revenue, 2011 – 2013 (USD Million)

FIG. 41 Medtronic, Inc., Annual Revenue: 2011 – 2013 (USD Million)

FIG. 42 Stryker Corporation: Annual Revenue: 2011 – 2013 (USD Million)

FIG. 43 Zimmer Holdings, Inc. Annual Revenue: 2011 – 2013 (USD Million)

List of Tables

TABLE 1 Market Snapshot: Global Craniomaxillofacial Implants Market

TABLE 2 Global Craniomaxillofacial Implants Market Revenue, by Location, 2012 – 2022 (USD Million)

TABLE 3 Global Craniomaxillofacial Implants Market Revenue, by Composition, 2012 – 2022 (USD Million)

TABLE 4 Global Craniomaxillofacial Implants Market Revenue, by Nature, 2012 – 2022 (USD Million)

TABLE 5 Global Craniomaxillofacial Implants Market Revenue, by Product, 2012 – 2022 (USD Million)

TABLE 6 Global Craniomaxillofacial Implants Market Revenue, by Geography, 2012 – 2022 (USD Million)

TABLE 7 North America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 8 Europe Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 9 Asia Pacific Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 10 Latin America Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

TABLE 11 MENA Craniomaxillofacial Implants Market Revenue, by Country, 2012 – 2022 (USD Million)

★調査レポート[頭蓋顎顔面インプラントの世界市場] (コード:TMR602214)販売に関する免責事項を必ずご確認ください。
★調査レポート[頭蓋顎顔面インプラントの世界市場]についてメールでお問い合わせ


◆H&Iグローバルリサーチのお客様(例)◆